   Ratings changes for Microsoft, Microsoft, Baozun, Ritter Pharmaceuticals, Alphabet, Celgene, Sucampo Pharmaceuticals and more...Be sure to add MarketBeat.com to your safe-sender list or address book to ensure your newsletter gets delivered to your inbox. Click Here to Learn How. Unsubscribe. Report Spam. |
 |    |
Save $100.00 on Your Subscription to MarketBeat Daily Premium (Ends 12/31!) Why Upgrade to MarketBeat Daily Premium? - You'll receive actionable news, ratings, excerpts from research notes, earnings, dividends, insider trades, options activity and technical data for stocks you're interested in, a full 30 minutes before the NYSE opens.
- You'll get breaking news alerts via email or SMS when important news happens for stocks on your watchlist.
- You can follow an unlimited number of stocks on your watchlist and in our portfolio monitoring tool (My MarketBeat).
- You'll get additional ratings and price target changes which are not included in the free version of MarketBeat Daily.
- You'll receive our closing bell wrap-up that contains mid-day analyst ratings changes, earnings announcements and headlines.
- You'll get a summary of all of the key earnings announcements, dividend announcements and insider trades of the day.
- You have the option to receive your newsletter in an easy-to-scan table format and the ability to export each day's data to Microsoft Excel.
Click Here to Subscribe to MarketBeat Daily Premium (Save $100.00!) |
|
Quick Links: My MarketBeat, Account Settings, Analyst Ratings, Company Profiles, Dividend Declarations, Earnings Announcements, Headlines & Insider Trades.
Here are today's top stories and analysts' upgrades, downgrades and new coverage brought to you by MarketBeat.com:
Top Stories
Urgent: Massive $34.6 Billion Payout Expected to Start as Early as Jan. 1 (Ad)
Thousands of U.S. taxpayers set to reap huge payouts in the biggest cash grab in history. But to get your share, you must be ready to cash in before Jan. 1.
Click here to see how to stake your claim now!
  Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)
You have not added any stocks to your watchlist.
Click here to add stocks from your portfolio to your watchlist.
Analysts' Upgrades
- Knoll (NYSE:KNL) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating. They now have a $26.00 price target on the stock, up previously from $23.00. 18.0% upside from the current price of $22.04. Read More.
- Herman Miller (NASDAQ:MLHR) was upgraded by analysts at Raymond James Financial, Inc. from a "market perform" rating to an "outperform" rating. They now have a $43.00 price target on the stock. 13.3% upside from the current price of $37.95. Read More.
- UNITIL (NYSE:UTL) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $50.00 price target on the stock, down previously from $52.00. They noted that the move was a valuation call. 12.8% upside from the current price of $44.32. Read More.
- View today's most recent analysts' upgrades at MarketBeat.com
Can You Make $2,000 A Week Trading My Money? (Ad)
If you're serious about learning how to become a better trader, they'll fund your trading account up to $250,000 while you learn the strategies and techniques that will help make you the best trader that you can be. The funds they allocate are limited so don't miss this opportunity.
Click Here to Learn More
  Analysts' Downgrades
- Agile Therapeutics (NASDAQ:AGRX) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating. current price of $2.52. Read More.
- 1-800 FLOWERS.COM (NASDAQ:FLWS) was downgraded by analysts at Northcoast Research from a "buy" rating to a "neutral" rating. current price of $11.35. Read More.
- KLX (NASDAQ:KLXI) was downgraded by analysts at Buckingham Research from a "buy" rating to a "neutral" rating. current price of $63.00. Read More.
- Ignyta (NASDAQ:RXDX) was downgraded by analysts at Ladenburg Thalmann Financial Services from a "buy" rating to a "neutral" rating. current price of $26.85. Read More.
- Ignyta (NASDAQ:RXDX) was downgraded by analysts at SunTrust Banks, Inc. from a "buy" rating to a "hold" rating. They now have a $27.00 price target on the stock, up previously from $25.00. 0.6% upside from the current price of $26.85. Read More.
- Sucampo Pharmaceuticals (NASDAQ:SCMP) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating. current price of $17.00. Read More.
- Sucampo Pharmaceuticals (NASDAQ:SCMP) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. current price of $17.00. Read More.
- View today's most recent analysts' downgrades at MarketBeat.com
New Traders Wanted: We Provide ALL Trading Capital & Training (Ad)
If you'd like to learn to trade with NO risk to your own capital - you need to attend this Free Online Investing Seminar.
We will fund your trading account - up to $250,000. The better trader you become - the more trading capital we'll provide.
Funds are limited so don't miss this once-in-a-lifetime opportunity. To select a convenient time to learn more, just click on this link:
REGISTER HERE
  The Next Bitcoin (Is Here) (Ad)
In the ninth year of one of the longest bull markets ever, the cryptocurrency market is completely outpacing traditional investments. It's even skyrocketing past gold and is likely to continue doing so -- which is why the time to buy is now. But choosing which cryptocurrency is best can be difficult. Don't fret -- we've got you covered.
Read this special report to get started...
  Analysts' Price Target Changes
- Corium International (NASDAQ:CORI) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $14.00. They now have a "buy" rating on the stock. 35.8% upside from the current price of $10.31. Read More.
- FedEx (NYSE:FDX) had its price target raised by analysts at Argus from $245.00 to $290.00. They now have a "buy" rating on the stock. 16.0% upside from the current price of $250.02. Read More.
- Kroger (NYSE:KR) had its price target raised by analysts at Citigroup Inc from $30.00 to $33.00. They now have a "buy" rating on the stock. 18.7% upside from the current price of $27.79. Read More.
- Ingevity (NYSE:NGVT) had its price target lowered by analysts at Loop Capital from $83.00 to $80.00. They now have a "buy" rating on the stock. 12.8% upside from the current price of $70.95. Read More.
- Nike (NYSE:NKE) had its price target raised by analysts at DA Davidson from $68.00 to $78.00. They now have a "buy" rating on the stock. 22.5% upside from the current price of $63.65. Read More.
- Smart Global (NASDAQ:SGH) had its price target raised by analysts at Needham & Company LLC from $43.00 to $46.00. They now have a "strong-buy" rating on the stock. 34.4% upside from the current price of $34.23. Read More.
- XPO Logistics (NYSE:XPO) had its price target raised by analysts at Citigroup Inc from $75.00 to $110.00. They now have a "buy" rating on the stock. 23.6% upside from the current price of $89.01. Read More.
- View additional analysts' coverage at MarketBeat.com
Upgrade to MarketBeat Daily Premium and receive your premium edition of MarketBeat Daily at 9:00 AM ET. Start Your Risk-Free Trial Today.
More Info: U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Conference Calls, Dividends, Earnings, Economic Reports, Insider Trades, IPOs, Short Interest & Stock Splits
Get Our App: Click Here to download MarketBeat's free smartphone app. Available for Android, iPhone and iPad. |
This message was sent by MarketBeat.com and may contain commercial elements (such as advertising). Why did I receive this email?
If you would like to unsubscribe or change which emails you receive, Manage Your Mailing Preferences or Unsubscribe From These Emails.
If you have questions about your subscription, feel free to contact us via email at contact@marketbeat.com.
© 2006-2017 American Consumer News, LLC dba MarketBeat.com. 1401 S. Discovery Ave., Sioux Falls, SD 57106. United States.
[12/26/2017 3:21:42 PM - 27.3 KB] |
No comments:
Post a Comment